1S2A | date | ![]() |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | |||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | |||||||||||||
ligand | DMS, IMN, NAP, UNX BindingDB | enzyme |
| ||||||||||||
related structures | by homologous chain: 1RY0, 1S2C | ||||||||||||||
Gene Ontology ![]() |
| ||||||||||||||
Primary reference | Crystal structures of prostaglandin D(2) 11-ketoreductase (AKR1C3) in complex with the nonsteroidal anti-inflammatory drugs flufenamic acid and indomethacin., Lovering AL, Ride JP, Bunce CM, Desmond JC, Cummings SM, White SA, Cancer Res 2004 Mar 1;64(5):1802-10. PMID:14996743 |
Data retrieval |
![]() |
View 1S2A in 3D |
![]() |
Structure-derived information |
Sequence-derived information |
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |